HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

13th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2026

October 19 -21, 2026 | Boston, Massachusetts, USA
INBC 2026

Epidemiological trends of Meningococcal meningitis in Brazil (2008–2023)

Speaker at Neurology Conferences - Beatriz Zincone Milan Lise
Sao Leopoldo Mandic Medical School, Brazil
Title : Epidemiological trends of Meningococcal meningitis in Brazil (2008–2023)

Abstract:

Introduction: Meningococcal meningitis is a major public health concern in Brazil, where the disease is subject to compulsory notification via the Brazilian Notifiable Diseases Information System (SINAN).
Objective: The main purpose of this study was to evaluate temporal trends in the incidence and mortality rates of meningococcal meningitis in Brazil from 2008 to 2023.
Methods: A retrospective, descriptive study using secondary data from DATASUS - SINAN. The analysis included variables such as age group (< 1year (y), 1 - 4y, 5 - 9y, 10 - 19y, 20 - 39y, 40 - 59y, 60 - 64y, 65 - 69y, 70 - 79y, and > 80 y), epidemiological year, incidence, number of deaths due to meningococcal meningitis, and mortality rate per 100,000 inhabitants.
Results: Between 2008 and 2023, a total of 272,591 cases of meningitis and meningococcemia were reported. Highest incidence was evidenced in 2009 with important decreases in cases afterwards. From 2021 to 2022, confirmed cases increased by 100%, with a pronounced rise in children between 1 to 4y (from 5 to 20 cases per 100,000 inhabitants) and 5 to 9y (from 2 to 10 cases per 100,000 inhabitants). During the study period, 25,649 total deaths were recorded. The peak mortality rate occurred in 2009, reaching 11.2 deaths per 100,000 inhabitants. The most significant year-over-year increase was observed between 2021 and 2022, with a 70.27% rise. Children under one year of age presented the highest mortality rate, increasing from 2.77 deaths per 100,000 inhabitants in 2021 to 11.15 in 2022. Our results show increased mortality at the extremes of age, with the highest rates in children under 5 and in adults over 60. 
Conclusion: The data indicate a substantial decline in both the incidence and mortality rates of meningococcal meningitis after 2009 likely due to introduction of vaccines and changes in rates from 2021 to 2022 possibly influenced by the social and health context brought by the COVID-19 pandemic.

Biography:

The presenting author is a senior medical student (fifth year of a six-year program) and a student member of the Brazilian Academy of Neurology. Her academic interests include Neurology and Intensive Care Medicine, with a focus on clinical research, data analytics, and healthcare innovation. She is currently pursuing international academic and research opportunities to further develop her experience in clinical neurology.

Watsapp